Abstract
Donepezil (Aricept) is a therapeutic drug for the treatment of Alzheimer's disease (AD). However, there have been only two reports describing the effects of donepezil on sleep as assessed by nocturnal polysomnography (PSG). With this in mind, the effects of donepezil on the sleep of healthy subjects was evaluated using PSG. The results indicated that the percentage of rapid eye movement sleep to total sleep time was increased significantly by a single dose of 5 mg of donepezil when given to healthy subjects immediately before retiring to bed.
| Original language | English |
|---|---|
| Pages (from-to) | 307-308 |
| Number of pages | 2 |
| Journal | Psychiatry and clinical neurosciences |
| Volume | 56 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Neuroscience
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Effects of donepezil (Aricept) on the rapid eye movement sleep of normal subjects'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver